Figure 1From: Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancerOvarian cancer patient derived MSC (ovMSC) retains multi-potent lineage. Representative results of in vitro differentiation of MSC into adipocytes, osteocytes and chondrocytes post culture in differentiation media. Respective stains used are as indicated. hMSC: healthy donor MSC.Back to article page